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ABSTRACT 
Objective: Visual hallucinations (VH) most commonly occur in eye disease (ED), Parkinson’s disease 
(PD), and Lewy body dementia (LBD). The phenomenology of VH is likely to carry important 
information about the brain areas within the visual system generating them. Methods: Data from five 
controlled cross-sectional VH studies (164 controls, 135 ED, 156 PD, 79 (PDD 48 + DLB 31) LBD) were 
combined and analysed. The prevalence, phenomenology, frequency, duration, and contents of VH were 
compared across diseases and gender. Results: Simple VH were most common in ED patients (ED 65% 
vs. LBD 22% vs. PD 9%, Chi-square [χ2] test: χ2=31.43, df=2, p<0.001), whilst complex VH were more 
common in LBD (LBD 76% vs. ED 38%, vs PD 28%, Chi-square test: χ2=96.80, df=2, p<0.001). The 
phenomenology of complex VH was different across diseases and gender. ED patients reported more 
“flowers” (ED 21% vs. LBD 6% vs. PD 0%, Chi-square test: χ2=10.04, df=2, p=0.005) and “body parts” 
(ED 40% vs. LBD 17% vs. PD 13%, Chi-square test: χ2=11.14, df=2, p=0.004); in contrast LBD patients 
reported “people” (LBD 85% vs. ED 67% vs. PD 63%, Chi-square test: χ2=6.20, df=2, p=0.045) and 
“animals/insects” (LBD 50% vs. PD 42% vs. ED 21%, Chi-square test: χ2=9.76, df=2, p=0.008). Males 
reported more “machines” (13 % vs. 2%, Chi-square test: χ2=6.94, df=1, p=0.008), whilst females 
reported more “family members/children” (48% vs. 29%, Chi-square test: χ2=5.10, df=1, p=0.024). 
Conclusions: The phenomenology of VH is likely related to disease specific dysfunctions within the 
visual system and to past, personal experiences. 
 
 
 
Keywords: Visual hallucinations, phenomenology, Lewy body dementia, Parkinson’s disease, eye 
disease 
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Recurrent visual hallucinations (VH) are visual perceptions in the absence of an appropriate 
external visual stimulus. In later life, they occur mainly in the context of eye disease (ED)(1-3) and Lewy 
body diseases such as Parkinson’s disease (PD)(4, 5) and Lewy body dementia (LBD) including 
Parkinson’s disease dementia (PDD)(5-7) and dementia with Lewy bodies (DLB).(2, 7, 8) There are 
numerous studies examining VH in these specific diseases; however, there has been very little direct 
comparison of phenomenology across diseases.(9) 
 
The phenomenology of VH is commonly classified into simple VH,(10) passage hallucinations / the 
feeling of presence,(11) visual illusions,(12) and complex VH.(7) Simple VH lack recognizable form and 
refer to dots, lines, shapes, patterns, and flashes.(10, 13) Complex VH are well-formed and include faces, 
people, animals, objects or landscapes.(7, 13, 14) The feeling of presence involves the sense of a person 
being present but not clearly visible in the room or house.(11) Illusions refer to experiences where it is 
clear that one object is distorted into another – for example, see a person in a curtain or perceive blobs on 
the wall as faces.(12)  
 
The phenomenology of VH likely refers to underlying dysfunction within the visual system.(13, 15, 16) 
Imaging of higher visual processing areas within the ventral and dorsal visual pathways in ED,(15) 
PD,(17-19) and DLB(8, 20) has indicated that specific content may be related to particular patterns of 
neural activity. For example, a case report in ED suggested that VH consisting of letters or words are 
related to the left posterior fusiform gyrus, the visual word form area(21) whilst VH involving colour, 
faces, textures, and objects are due to increased activity in the ventral occipital lobe.(15) Functional 
magnetic resonance imaging studies show increased activation in the visual association cortex with 
deficits in the primary visual cortex(17) and hyper-activation in the frontal lobes in PD patients with 
VH.(19) In DLB, abnormalities in the occipitoparietal visual area have been related to VH(20) with 
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complex VH of images of people associated with hypoperfusion in the bilateral parietal areas and left 
ventral occipital gyrus.(22)  
VH is mostly assessed using questionnaires relying on informant or patient information. Existing 
questionnaires tend to underestimate the characteristics of VH.(11) Very few are designed to be used 
across diseases. The North East Visual Hallucination Inventory (NEVHI)(3) is an exception and has been 
developed for patients with visual and/or cognitive impairments and screens for different phenomenology 
and characteristics including frequency and severity. The aim of the present study was to compare the 
phenomenology and characteristics of VH in ED, PD, LBD patients using the NEVHI(3) interview based 
on patient information.(23) We hypothesized that the phenomenology and characteristics of VH would be 
different across diseases. We further explored the effects of gender on hallucinatory content. 
 
METHODS  
Study Selection and Data Collection 
There have been several studies(2-5, 8, 24) using NEVHI(3) since its original publication in 2008. Only 
controlled cross-sectional NEVHI studies with ED, PD, PDD, and DLB samples using similar 
methodology were included in this study. Three(3, 4, 8) of them had two sample groups (patients, 
controls), while the other two had three sample groups (controls, ED, DLB;(2) controls, PD, PDD(5)). 
The control groups which included friends/relatives(2, 8) or spouses of patients,(2, 3, 5, 8) volunteers 
recruited via advertisement in the Newcastle Elders magazine(4) and in a local church(3, 4) and healthy 
controls from the research database held at the Institute for Ageing, Newcastle University(3, 5) comprise 
the comparison group in this study. Diagnostic criteria were met using the revised International 
Consensus Guidelines from the third report of the DLB consortium for DLB, the Movement Disorder 
Society consensus criteria for dementia associated with PD for PDD, and the UK PD Society Brain Bank 
Clinical Diagnostic Criteria for PD. The principal investigators of these studies agreed to contribute their 
original data for the present study. Data were collected in accordance with the latest version of the 
Declaration of Helsinki and was approved by the National Health Service (NHS) Research Ethics 
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Committee, United Kingdom. All procedures related to the study were explained to the participants and a 
written informed consent was obtained prior to participation. All data were merged into a single database 
including 164 individuals in the comparison group and 383 patients (135 ED, 156 PD, 48 PDD, 31 DLB, 
13 with combination of ED/PD/PDD/DLB). The latter 13 patients were excluded from further analysis. A 
sub-analysis of VH phenomenology did not reveal any differences between DLB and PDD patients, 
which were subsequently considered as one LBD group. PD and LBD patients were only included if they 
had no visual field defects on neurological examination. 
 
Assessments 
An interview was used to gather demographic data in all studies. Best near visual acuity was examined 
using Landolt broken rings or Snellen Charts at a test distance of 40 cm.(25) The Mini Mental State 
Examination (MMSE)(26) was used as screening instrument for global cognition. The maximal score was 
29 in the ED (omission of overlapping pentagon drawing)(24) and 30 for all other groups. The verbal 
fluency test (FAS)(27) and category (animal) fluency test(27) assessed the executive and language skills. 
The verbal fluency scores were averaged across three one-minute trials. The Unified Parkinson’s Disease 
Rating Scale (UPDRS III)(28) served as a measure to quantify extrapyramidal motor features. The Mayo 
sleep questionnaire(29) screened for the presence of rapid eye movement sleep behaviour disorder (RBD) 
and the Epworth Sleepiness scale (ESS)(30) was the screening measure for excessive daytime 
somnolence. The accepted cut-off for excessive daytime somnolence using the ESS was set to a score of 
10. Clinical parameters specific to Lewy body diseases (UPDRS, RBD, ESS) were assessed in PD, PDD, 
and DLB patients only. The NEVHI(3) screens for the presence and phenomenology of VH, and 
establishes the duration and frequency of hallucinations. Section 1 of the NEVHI assesses the presence 
and phenomenology of VH (simple VH and complex VH, visual illusions, passage of shadows, feeling of 
presence), section 2 the frequency, duration of VH and section 3 assesses perceived severity (i.e. the 
emotions, cognitions associated with VH). A detailed description of the questionnaire can be found 
elsewhere.(3) Complex VH were grouped into the categories: “people” (anonymous or family 
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members/children), “body parts”, “animals/insects”, “machines”, and “letters/numbers/musical notes”.(7, 
13, 15) Prevalence, phenomenology, frequency, duration and severity of VH were compared between the 
(i) comparison group and patients and (ii) different patient groups (ED, PD, LBD). The phenomenology 
of Complex VH was also compared between gender. 
 
Statistical analysis 
Statistical analysis was undertaken using the Statistical Package for Social Sciences (SPSS Version 20). 
Normal distribution of data was examined using the Shapiro-Wilk test. Means and standard deviations 
(SD) were calculated. Data were analysed using parametric tests (one-way analysis of variance 
(ANOVA)). Multiple comparisons were assessed with Post-hoc Bonferroni tests. Frequencies were 
compared using the chi-square (χ2) test and Fisher’s exact test when expected frequency in either group 
was < 5. The effect of gender, disease and interaction of gender × disease on contents of complex VH was 
tested using a two-way ANOVA (Effect sizes are reported using partial η2), whilst logistic regression was 
used to ascertain whether the VH phenomenology could significantly predict the disease. The 
homogeneity of variance of the interaction model was tested using Levene’s test, while goodness-of-fit of 
the regression model was tested using Hosmer and Lemeshow test. All reported p-values are two-tailed 
and a p-value < 0.05 was considered significant. 
 
RESULTS 
Demographics 
The demographics and clinical characteristics are summarised in Table 1. The groups did not differ in 
education, but females were overrepresented in the ED group and the ED and LBD groups tended to be 
older than the other groups. The ED group had, as expected, the lowest visual acuity score and the LBD 
group performed poorest in all cognitive measures (MMSE, verbal and categorical fluency) compared to 
all other groups. When the PD and LBD groups were compared disease duration was not different, but the 
Page 6 of 20
7 
 
LBD group had higher UPDRS III scores. PD and LBD had also higher ESS and more RBD than the ED 
or comparison groups.  
 
-Table 1 about here- 
 
Visual hallucination phenomenology 
The 1-year prevalence of any type of VH was not different between ED and LBD (84% vs. 86%; Chi-
square test: χ2 = 0.22, df = 1, p = 1.000), but the ED and LBD groups had more VH than the PD patients 
(PD vs. ED: 66% vs. 84%, Chi-square test: χ2 = 11.82, df = 1, p = 0.002; PD vs. LBD: 66% vs. 86%, Chi-
square test: χ2 = 10.64, df = 1, p = 0.004). The phenomenology of VH across diseases is summarised in 
Table 2. Complex VH were exclusively found in patients and not in the comparison group, although some 
in the comparison group reported visual illusions. Complex VH were most commonly observed in LBD 
patients and the observed 1-year prevalence was two or three times higher than in PD or in ED. In 
addition, the passage of shadow and feeling of presence were more common in LBD than in the other 
groups, but the group differences were less distinct. The simple VH were the most common hallucination 
in ED, while they are rarely observed in PD or in the comparison group.  
 
-Table 2 about here- 
 
Frequency, duration and distress of visual hallucinations 
The VH of patients occurred more frequently (weekly or daily) compared to those in the comparison 
group (monthly) as shown in Table 3. Daily hallucinations were most commonly reported by the ED 
patients, whereas LBD and PD patients experienced them on a weekly or monthly basis. The VH occurred 
for minutes to maximal 2 hours with no major difference between the groups. Long-lasting hallucinations 
(> 2 hours) were rare and commonly reported by LBD patients. A tendency to more irritating and 
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frightening hallucinations was found in LBD whilst only a minority of the ED and PD patients found their 
hallucinations distressing. 
 
- Table 3 about here - 
 
Phenomenology of complex visual hallucinations across diseases 
The details of the phenomenology of complex VH in patients are summarized in Table 4. The most 
common complex VH experienced was of “people”, followed by “animals/insects”. ED patients reported 
more “flowers” and “body parts” than the other groups and LBD patients more often reported 
hallucinations containing “people”. 
 
- Table 4 about here - 
 
Phenomenology of complex visual hallucinations across gender  
The differences in the phenomenology of complex VH across gender irrespective of the diseases are 
summarized in Table 5. Both male and female patients reported “people” equally frequently. However, 
“family members/children” were more commonly reported by females and “anonymous people” were 
more common in males. In addition, VH containing “body parts” were more often reported by female 
patients, whilst male patients reported more VH containing “machines”.  
 
- Table 5 about here - 
 
Effect of gender, disease and interaction of gender × disease on complex visual hallucination 
phenomenology 
There was a main effect of gender on “anonymous people” (two-way ANOVA: F (df 1,134) = 5.109, p = 
0.025, partial η2 = 0.037), “family members/children” (two-way ANOVA: F (df 1,136) = 8.172, p = 
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0.005, partial η2 = 0.057 ), and “machines” (two-way ANOVA: F (df 1,136) = 9.531, p = 0.002, partial η2 
= 0.065), whilst disease had a main effect on “people” (two-way ANOVA: F (df 2,136) = 3.331, p = 
0.039, partial η2 = 0.047), “family members/children” (two-way ANOVA: F (df 2,136) = 3.994, p = 
0.021, partial η2 = 0.055), “body parts” (two-way ANOVA: F (df 2,136) = 3.328, p = 0.039, partial η2 = 
0.047), “animals/insects” (two-way ANOVA: F (df 2,136) = 5.042, p = 0.008, partial η2 = 0.069), and 
“flowers” (two-way ANOVA: F (df 2,126) = 7.163, p = 0.001, partial η2 = 0.102). Two of the above main 
effects were qualified by a significant gender × disease interaction which was only present in ED with a 
female gender effect on “family members/children” (two-way ANOVA: F (df 1,136) = 5.093, p = 0.026, 
partial η2 = 0.036) and a male gender effect on “machines” (two-way ANOVA: F (df 1,136) = 7.973, p = 
0.005, partial η2 = 0.055). 
 
Association between the visual hallucination phenomenology and diseases: 
The significant disease predictors were simple VH for ED (Logistic regression: Odds ratio [OR] = 12.1, 
95% confidence interval [CI] = 6.653 – 21.939, Wald χ2 = 67.004, df = 1, p < 0.001, Nagelkerke R2 = 
0.396), feeling of presence/passage for PD (Logistic regression: OR = 1.910, 95% CI = 1.065 – 3.425, 
Wald χ2 = 4.719, df = 1, p = 0.030, Nagelkerke R2 = 0.160) and complex VH for LBD (Logistic 
regression: OR = 13.126, 95% CI = 5·928 – 29·063, Wald χ2 = 40.303, df = 1, p < 0·001, Nagelkerke R2 
= 0·310). 
 
DISCUSSION 
This study assessed the prevalence and phenomenology of VH in the comparison group, ED, PD and 
LBD using the same standardised and validated assessment. As hypothesised, the phenomenology of VH 
was different across diseases: (i) simple VH were most commonly experienced in ED whilst complex VH 
was the most common form of hallucination in LBD, (ii) VH occurred more frequently in ED (daily 
basis) than in PD and LBD, (iii) longer, irritating and frightening episodes of VH were common in LBD, 
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(iv) complex VH features like “people”, “family members/children” were reported more frequently in 
LBD, whilst “flowers” and “body parts” were reported more commonly in ED. In addition, female 
patients reported more hallucinations of “family members/children”, while male patients reported more 
“machines”. The predictors for diseases were simple VH for ED, feeling of presence/passage for PD and 
complex VH for LBD. 
 
This is the first time that VH phenomenology and characteristics were compared across diseases in which 
VH are common using the same methodology and a largest ever published sample size for these diseases. 
The 1-year prevalence of VH in our combined study are in line with the individual ED, PD and LBD 
studies reported before.(3, 5, 13) However, the 1-year prevalence of complex VH in PD in our study is 
lower owing to the clear differential diagnosis of PD and PDD, which before the year 2004 were studied 
as a single group. Our results confirm the highest prevalence of simple VH in ED(13, 31) and highest 
prevalence of complex VH in LBD.(7) This supports the assumption that simple VH are related to 
pathology within the primary retino-cortical visual system,(31) whereas complex VH are likely tied to 
higher cortical dysfunction in the context of LB pathology;(13, 14, 16, 31) for example, LB pathology 
within the temporal and ventral visual stream has been linked to a higher prevalence of complex VH in 
LBD.(16) In addition, the well-formed quality of complex VH suggests involvement of regions outside 
the primary visual areas. In our study, both complex VH and irritating, frightening episodes of VH were 
common in LBD, whereas increased visual excitability has been previously reported as a marker for 
frequency × severity of complex VH in LBD.(8) The two different predictors, simple VH for ED and 
complex VH for LBD also support assumptions that VH are clinically useful disease-specific 
predictors.(6)  
 
Comparing our results with previous studies,(7, 10, 11, 13) features like “inverse hats” reported 
previously in ED patients(13) were rarely reported by our patients, but overall our results are in line with 
studies that have reported features like “people” and “animals” as the most common categories of images 
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in complex VH.(7, 10, 11) As with earlier studies where VH content tends to be familiar in PD,(11) our 
study found that the complex VH content were well-formed and familiar in LBD. High densities of LB in 
the amygdala and the parahippocampus, areas upon which judgements of familiarity depend, are in fact 
associated with well-formed CVH in LBD.(16) However it is not clear that recognition of VH content as 
familiar is necessarily reliable. 
 
The so-called “continuity hypothesis”(32) contends that dream images are often an extension of waking 
day thoughts, feelings and behaviours that can possibly be extended to hallucinations. Accordingly, VH 
may refer to real life experiences of which family members and friends can be the most common 
phenomenology. Females reporting more about “family members/children” and males more on 
“machines” suggest that the content of complex VH is presumably influenced by personal experience.(33) 
 
The strength of this study lies in its large sample size and its focus on the phenomenology of VH. The 
pooling of data and the use of similar methodology to characterise patients or VH allowed a more 
thorough analysis of sub-groups than in previous studies. However, since data was combined across 
studies, findings will need to be confirmed within a single group comparison.  
 
CONCLUSIONS 
Our main findings, namely that the phenomenology and characteristics of VH are different across 
diseases and are related to past personal experiences, provide mounting evidence and may inform models 
of mechanisms underpinning this link. There is further a clear need for future studies that link the 
pathophysiology within the visual system to the phenomenology of VH. 
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TABLE 1. Clinical and demographic characteristics (n = 534) 
 
 
Comparison 
group 
n = 164 
Patients  
Statistics p ED  
n = 135 
PD  
n = 156 
LBD 
 n = 79 
Age (years) 72.9 (8.2) 79.8 (8.3) 70.9 (9.4) 74.8 (7.4) F=28.59
Z
,
 
5.62
A
, 
71.89
B
,19.98
C
, 9.91
D
 
<0.001
Z,B,C
, 0.018
A
, 
0.007
D
 
Female (%) 92 (56) 93 (69) 64 (41) 23 (29) χ
2
=40.34
Z
, 2.52
A
, 
22·61
B
, 31.76
C
, 3.19
D 
<0.001
Z,B,C
, 0.449
A
 , 
0.296
D
 
Education (years) 11.5 (3.2) 10.7 (2.2) 10.9 (3.2) 10.8 (2.2) F =2.61
Z
,
 
7.37
A
, 0.53
B
, 
0.09
C
, 0.07
D
 
0.051
Z
, 0.007
A
, 1.000
B
, 
1.000
C
, 1.000
D
 
Visual acuity (decimals) 0.48 (0.22) 0.19 (0.18) 0.42 (0.20) 0.35 (0.15)
 
F =52.71
Z
, 71.06
A
, 
75.81
B
, 17.27
C
, 2.93
D 
<0.001
Z,A,B
, 0.001
C
, 
0.574
D
 
MMSE [max = 30] 28.5 (1.7) 27.1 (1.9) 28.2 (2.3) 21.6 (4.5) F =152.18
Z
, 43.87
A
, 
20.50
B
, 149.86
C
, 223.67
D
 
<0.001
Z,A,C,D
, 0.001
B
 
Verbal fluency (words per 
minute) 
13.2 (5.3) 11.5 (5.0) 12.3 (5.7) 5.9 (4.1) F =5.15
Z
, 6.02
A
, 1.06
B
, 
7.97
C
, 8.07
D
 
0.002
Z
, 0.015
A
, 1.000
B, 
0
.
052
C
 ,0.017
D
  
Categorical fluency (animals 
per minute) 
21.3 (6.8) 14.2 (3.6) 16.5 (5.9) 8.9 (3.5) F =34.79
Z
, 60.14
A
, 4.66
B
, 
35.76
C
, 37.65
D
 
<0.001
Z,A,D
, 0.265
B
, 
0.002
C
 
Parkinsonism duration (years) n.a n.a  8.4 (5.6) 8.5 (6.3)
 
F =0.003
D 
0.959
D
 
UPDRS III [max = 67] n.a n.a 22.5 (10.3) 31.7 (15.3)
 
F =22.7
D
 <0.001
D 
 
ESS [max = 24] 4.4 (3.4) 5.5 (0.7) 8.2 (5.5) 11.8 (4.4)
 
F =23.91
Z
, 54.94
A
, 
0.487
B
, 3.97
C
, 10.47
D 
<0.001
Z,A
, 1.000
B
, 
0.408
C
, 0.002
D
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RBD likely (%) 4 (3) 1 (1) 58 (37) 35 (44) χ
2
=88.99
Z
, 73.86
A
, 
12.69
D 
<0.001
Z,A,D
, °1.000
B
, 
°1.000
C
 
Data are mean and (SD) unless specified otherwise; Statistics are one-way ANOVA (F) or chi-square (χ2) tests or °Fisher’s Exact; MMSE = Mini-Mental State Examination, UPDRS = 
Unified Parkinson’s Disease Rating Scale – motor evaluation, ESS = Epworth Sleeping Scale; RBD = Rapid eye movement sleep behavior disorder; ED = Eye disease; PD = Parkinson’s 
disease; LBD = Lewy body dementia; n.a = not available; Z comparison across all groups, df =3; A comparison group vs. patients, df =1; B ED vs. PD, df =1; C ED vs. LBD , df =1; D PD vs. 
LBD, df =1; 
 
 
TABLE 2. The phenomenology of visual hallucinations across diseases 
 
Comparison 
group 
n = 164 
Patients 
Statistics (χ2) p ED  
n = 135 
PD  
n = 156 
LBD 
n = 79 
Complex visual 
hallucinations 
0 (0) 52 (38) 43 (28) 60 (76) 157.57Z, 96.80A, 3.95B, 
27.99
C
, 49.87
D 
<0.001
Z,A,C,D
, 
0.188
B 
Illusion 15 (9) 22 (16) 42 (27) 34 (43) 41.87Z, 20.48A, 4.76B, 
18.45
C
, 6.22
D 
<0.001
Z,A,C
, 0.116
B
, 
0.050
D 
Passage of shadow / 
Feeling of presence 
34 (21) 57 (42) 82 (53) 52 (66) 55.96Z, 44.47A, 3.10B, 
11.11
C
, 3.76
D 
<0.001
Z,A
, 0.313
B
, 
0.003
C
, 0.210
D 
Simple visual 
hallucinations 
15 (9) 88 (65) 13 (8) 17 (22) 162.28Z, 31.43A, 
103.22
B
, 38.02
C
, 8.19
D 
<0.001
Z,A,B,C
, 
0.017
D 
Data are n (%);Statistics are chi-square (χ2) or Fisher’s exact tests; ED = Eye disease; PD = Parkinson’s disease; LBD = Lewy body dementia;  
Z comparison across all groups: df = 3; A comparison group vs. patients: df = 1; B ED vs. PD: df = 1; C ED vs. LBD: df = 1; D PD vs. LBD: df = 1; 
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TABLE 3. Frequency, duration and distress of visual hallucinations across diseases 
 Comparison 
group 
ED PD LBD 
Statistics (χ2) p 
Frequency n = 24# n = 101# n = 79# n = 55# 
Less than once a week 17 (71) 14 (14) 33 (42) 16 (30) 36.12
Z
, 19.77
A
, 17.89
B
, 
5.32
C
, 2.25
D
 
<0.001
Z,A,B
, 0.084
C
, 
0.535
D
 
1-6 times a week 3 (3) 38 (38) 32 (41) 29 (53) 11.54
Z
, 8.01
A
, 0.16
B
, 3.31
C
, 
1.95
D
 
0.009
Z
, 0.019
A
, 1.000
B
, 
0.275
C
, 0.649
D
 
Daily 1 (2) 34 (34) 14 (18) 10 (18) 13.34
Z
, 5.21
A
, 5.76
B
, 4.22
C
, 
0.01
D
 
0.004
Z
, 0.022
A
, 0.066
B
, 
0.160
C
, 1.000
D
 
Duration n = 13§ n = 101§ n = 74§ n = 49§   
Less than 5 min 3 (23) 50 (50) 32 (43) 18 (37) 4.60
Z
 0.203
Z
 
5 min to 2 hrs 10 (77) 44 (44) 40 (54) 25 (51) 5.95
Z
 0.114
Z
 
Longer than 2 hrs 0 (0) 3 (3) 2 (3) 6 (12) 8.29
Z
, 0.63
A
, 0.01
B
, 5.03
C
, 
4.41
D
 
0.040
Z
, 1.000
A,B
, 0.1
C
, 
0.143
D
 
Distress n = 10¥ n = 91¥ n = 74¥ n = 49¥   
Irritating 0 (0) 28 (30) 13 (18) 31 (62) 32.77
Z
, 4.86
A
, 3.49
B
, 13.65
C
, 
25.73
D
 
<0·001
Z,C,D
, 0·110
A
, 
0.246
B
 
Frightening 0 (0) 27 (30) 11 (15) 25 (51) 23.16
Z
, 4.09
A
, 5.05
B
, 6.22
C
, 
18.62
D
 
<0.001
Z,D
, 0.172
A
, 0.099
B
, 
0.051
C
 
Data are n (%); Statistics are chi-square (χ2) or Fisher’s exact tests; ED = Eye disease; PD = Parkinson’s disease; LBD: Lewy body dementia; # = number of answers to sections 
corresponding to frequency of visual hallucination; § = number of answers the duration of visual hallucination section;¥ = number of answers to emotions associated with visual 
hallucination section; 
Z comparison across all groups: df = 3; A comparison group vs. patients: df = 1; B ED vs. PD: df = 1; C ED vs. LBD: df = 1; D PD vs. LBD: df = 1;  
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TABLE 4. Phenomenology of complex visual hallucinations (complex VH) across diseases 
Contents of complex VH 
ED with 
complex VH  
n = 52 
PD with 
complex VH  
n = 38 
LBD with 
complex VH 
n = 52 
Statistics (χ2) p 
People  35 (67.3) 24 (63.2) 44 (84.6) 6.20Z, 0.17B, 
4.27
C
, 5.47
D 
0.045
Z
, 1.000
B
, 
0.078
C
, 0.039
D 
anonymous people  
e.g.: soldiers, people  
24 (48.0) 14 (36.8) 27 (51.9) 2.09Z, 1.10B, 
0.16
C
, 2.02
D 
0.353
Z
, 0.886
B
, 
1.000
C
, 0.467
D 
family members, 
children 
18 (34.6) 10 (26.3) 26 (50.0) 5.63Z, 0.71B, 
2.52
C
, 5.13
D 
0.060
Z
, 1.000
B
, 
0.337
C
, 0.047
D 
Body parts  21 (40.4) 5 (13.2) 9 (17.3) 11.14Z, 7.92B, 
6.75
C
, 0.29
D 
0.004
Z
, 0.015
B
, 
0.028
C
, 1.000
D 
Animals & Insects  11 (21.2) 16 (42.1) 26 (50.0) 9.76Z, 4.59B, 
9.44
C
, 0.55
D 
0.008
Z
, 0.097
B
, 
0.006
C
, 1.000
D 
Machines  5 (9.6) 3 (7.9) 3 (5.8) 0.54Z, 0.08B, 
0.54
C
, 0.16
D 
0.763
Z
, 1.000
B
, 
1.000
C
, 1.000
D 
Flowers  11 (21.2) 0 (0) 3 (5.9) 10.74Z, 7.09B, 
5.11
C
, 1.77
D 
0.005
Z
, 0.023
B
, 
0.071
C
, 0.549
D 
Letters, Numbers, Musical 
Notes  
2 (3.8) 0 (0) 1 (1.9) 1.59Z, 1.49B, 
0.34
C
, 0.74
D 
0.453
Z
, 0.664
B
, 
1.000
C
, 1.000
D 
Data are n (%);Statistics are chi-square (χ2) or Fisher’s exact tests; ED = Eye disease; PD = Parkinson’s disease; LBD = Lewy body dementia; 
Z comparison across all groups: df = 2; B ED vs. PD: df = 1; C ED vs. LBD: df = 1; D PD vs. LBD: df = 1;  
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TABLE 5. Phenomenology of complex visual hallucinations (complex VH) across 
gender 
Contents of complex VH 
Males with 
complex VH  
n = 75 
Females with 
complex VH 
n = 67 
Statistic [df], p 
People  53 (70.7) 50 (74.6) χ2 [1] = 0.28, p = 0.598 
anonymous people  
e.g.: soldiers, people  
40 (54.8) 25 (37.3) χ2 [1] = 4.29, p = 0.038 
family members, 
children 
22 (29.3) 32 (47.8) χ2 [1] = 5.10, p = 0.024 
Body parts  12 (16.0) 23 (34.3) χ2 [1] = 6.40, p = 0.011 
Animals & Insects  29 (38.7) 24 (35.8) χ2 [1] = 0.12, p = 0.726 
Machines  10 (13.3) 1 (1.5) χ2 [1] = 6.94, p = 0.008 
Flowers  8 (11.4) 6 (9.7) χ2 [1] = 0.11, p = 0.744 
Letters, Numbers, Musical 
Notes  
3 (4.0) 0 (0.0) χ2 [1] = 2.74, p = 0.247 
Data are n (%); Statistics are chi-square (χ2) or Fisher’s exact tests with df =1. 
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